3,4-dihydroxybenzohydroxamic acid has been researched along with HIV Infections in 1 studies
HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
1 other study available for 3,4-dihydroxybenzohydroxamic acid and HIV Infections
| Article | Year |
|---|---|
Protease inhibitors and subtypes.
Topics: Benzamidines; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hydroxamic Acids; Serotyping; | 1999 |